Oren Bitton

Oren Bitton (chief executive) discloses dealings in Biosynex to AMF. Over a trading history stretching from 11 February 2022 to 14 February 2025, the count stands at 7 filings.

On the market, this insider has only ever bought: 6 purchases, €164k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Half of the purchases are above €22k and half below. 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 18 February 2025 with a transaction (€31k) in Biosynex. The last insider purchase was made public on 18 February 2022, 1,702 days ago. Between a trade and the moment it shows up on AMF, the median delay is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.